Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
9 hedge funds and large institutions have $6.53M invested in Aptose Biosciences, Inc. in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
6% more capital invested
Capital invested by funds: $6.16M → $6.53M (+$371K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$934K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$21.8K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$13.5K |
| 4 |
Morgan Stanley
New York
|
+$4.16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Callan Capital
La Jolla,
California
|
-$29K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$29K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$7.28K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.08K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $3.19M | – | – | – |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $2.23M | – | – | – |
|
|
BBA
3
Baker Bros. Advisors
New York
| $909K | +$934K | +898 | New |
|
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $112K | -$7.28K | -7 | -6% |
|
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $46K | +$21.8K | +21 | +84% |
|
|
6
Morgan Stanley
New York
| $20K | +$4.16K | +4 | +25% |
|
|
7
Bank of America
Charlotte,
North Carolina
| $14K | +$13.5K | +13 | New |
|
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $4K | +$2.08K | +2 | +100% |
|
|
9
UBS Group
Zurich,
Switzerland
| $3K | +$3.12K | +3 | New |
|
|
SIM
10
Sonora Investment Management
Tucson,
Arizona
| $18 | – | – | – |
|
|
CC
11
Callan Capital
La Jolla,
California
| – | -$29K | -27 | Closed |
|
|
KCM
12
Knoll Capital Management
Miami,
Florida
| – | -$29K | -27 | Closed |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| – | -$2.08K | -2 | Closed |
|
APTO Hedge Fund Activity: Q3 2016 in Review
9 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q3 2016, worth a combined $6.53M — up 6% from $6.16M a quarter earlier.
Fund positioning in APTO was balanced in Q3 2016: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $934K. The largest seller was Callan Capital, exiting entirely with an estimated $29K sold.
- 9 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $6.53M of Aptose Biosciences, Inc. stock for Q3 2016, up 6% quarter-over-quarter.
- 3 funds opened new Aptose Biosciences, Inc. positions in Q3 2016 and 3 closed out, a net change of 0 holders.
- The largest Aptose Biosciences, Inc. buyer in Q3 2016 was Baker Bros. Advisors, an estimated $934K added.
- The largest Aptose Biosciences, Inc. seller in Q3 2016 was Callan Capital, an estimated $29K sold.
Based on aggregated 13F filings for Q3 2016.